Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
AbbVie (NY: ABBV)
89.50 USD  +2.30 (+2.64%)
Official Closing Price  /  Updated: 7:51 PM EST, Jan 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 6,190,000
Open 88.45
Bid (Size) 88.76 (3)
Ask (Size) 89.85 (1)
Prev. Close 87.20
Today's Range 86.92 - 89.79
52wk Range 77.50 - 125.86
Shares Outstanding 1,586,879,451
Dividend Yield 4.01%
Performance
YTD
+0.30%
+0.30%
1 Month
+4.84%
+4.84%
3 Month
+6.21%
+6.21%
6 Month
+0.11%
+0.11%
1 Year
-14.47%
-14.47%
Top News
More News
AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer
-- The RESOLVE (PCYC-1137) trial evaluated ibrutinib in combination with chemotherapy agents nab-paclitaxel and gemcitabine versus placebo in combination with these chemotherapy agents Read More
from PR Newswire
UPDATE 1-AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study
AbbVie Inc said on Friday its blockbuster cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer. Read More
category companyNews
from Reuters: Company News
More News
Read More
On trade, China’s private-equity king is ‘hopeful for the best, prepared for the worst’
category CL , INTC , PG , and 18 more.
from MarketWatch
AbbVie's cancer drug fails to meet main goal in late-stage study
category companyNews
from Reuters: Company News
Noteworthy ETF Outflows: IUSG, NEE, ABBV, ISRG
category ETFs
from ETF Channel
U.S. lawmaker launches investigation into pharma drug pricing
category companyNews
from Reuters: Company News
These 3 Biotech Stocks Appear Poised To Beat Fourth-Quarter Forecasts
from Investor's Business Daily
1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn't (Yet)
category Market News , GILD , CELG , and 2 more.
from Motley Fool
House Democrats launch drug pricing probe into a dozen major health-care companies
category Politics , Pfizer Inc , Health Care , and 16 more.
from CNBC.com News
House Democrats launch probe into drug prices
category ABBV , Health/Care , NVS , and 9 more.
from MarketWatch
Noteworthy Friday Option Activity: TSLA, THS, ABBV
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.